Results
74,179 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 | Lie SeanChief Technology Officer |  CBRSCerebras Systems Inc.Gift · 10b5-1 plan | G | — 36.0K sh | Sep 28, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 | Lie SeanChief Technology Officer | CBRSCerebras Systems Inc. Gift · 10b5-1 plan | G | — 36.0K sh | Sep 28, 2026 |
| 5 | Hutman Hannah W.Director |  FMBMF&M BANK CORPGrant or award | A | $6,180 153 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America |  JXNJackson Financial Inc.Grant or award | A | — 19 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Duffey Gregory ADirector |  FRAFFRANKLIN FINANCIAL SERVICES CORP /PA/Grant or award | A | $3,195 51 sh | Sep 28, 2026 traded Sep 28, 2026 |
| 5 | Snook Gregory IDirector | FRAFFRANKLIN FINANCIAL SERVICES CORP /PA/ Grant or award | A | $6,453 103 sh | Sep 28, 2026 traded Sep 28, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | JXNJackson Financial Inc. Grant or award | A | — 25 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Keeler Anne BDirector | FMBMF&M BANK CORP Grant or award | A | $6,180 153 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Bhalla Narinder PalChief Medical Officer |  LXEOLexeo Therapeutics, Inc.Grant or award | A | — 54.8K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | JXNJackson Financial Inc. Grant or award | A | — 2 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | JXNJackson Financial Inc. Grant or award | A | — 18 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Radakovich Lynn VojvodichDirector |  DELLDell Technologies Inc.Grant or award | A | — 419 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Wray Peter HDirector | FMBMF&M BANK CORP Grant or award | A | $6,180 153 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Dorrance Bennett JRDirector |  CPBCAMPBELL'S CoGrant or award | A | — 2,204 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 5 | Malady KyleEVP and Group CEO-VZ Business |  VZVERIZON COMMUNICATIONS INCGrant or award | A | $1,739 129 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | JXNJackson Financial Inc. Grant or award | A | — 53 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Tamayo Louis EdwardChief Financial Officer | LXEOLexeo Therapeutics, Inc. Grant or award | A | — 54.8K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Otero Jose ManuelChief Operating Officer | LXEOLexeo Therapeutics, Inc. Grant or award | A | — 54.8K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner |  DUOLDuolingo, Inc.Option exercise · 10b5-1 plan | M | — 46.7K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Golechha DipakEVP, Chief Financial Officer |  PANWPalo Alto Networks IncOpen-market sale · 10b5-1 plan | SELL | $355K 900 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Tsao DavidDirector, Chief Technology Officer |  BLLNBillionToOne, Inc.Option exercise · 10b5-1 plan | M | $9,332 3,333 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Golechha DipakEVP, Chief Financial Officer | PANWPalo Alto Networks Inc Open-market sale · 10b5-1 plan | SELL | $842K 2,160 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Golechha DipakEVP, Chief Financial Officer | PANWPalo Alto Networks Inc Open-market sale · 10b5-1 plan | SELL | $866K 2,200 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Golechha DipakEVP, Chief Financial Officer | PANWPalo Alto Networks Inc Open-market sale · 10b5-1 plan | SELL | $350K 900 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Eisen Anthony MathewDirector |  XYZBlock, Inc.Open-market sale · 10b5-1 plan | SELL | $447K 6,000 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Eisen Anthony MathewDirector | XYZBlock, Inc. Open-market sale · 10b5-1 plan | SELL | $461K 6,000 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 4 | Eisen Anthony MathewDirector | XYZBlock, Inc. Open-market sale · 10b5-1 plan | SELL | $451K 6,000 sh | Sep 28, 2026 traded Sep 28, 2026 |
| 3 | Lie SeanChief Technology Officer | CBRSCerebras Systems Inc. Option exercise · 10b5-1 plan | M | — 3,125 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 3 | Song EstherSee Remarks |  SYNASYNAPTICS IncOpen-market sale · 10b5-1 plan | SELL | $15K 147 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 2 | Townsend Richard NolanDirector, Chief Executive Officer | LXEOLexeo Therapeutics, Inc. Grant or award | A | — 145.5K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 1 | Navratil TomasCHIEF DEVELOPMENT OFFICER |  GKOSGLAUKOS CorpOpen-market sale · 10b5-1 plan | SELL | $168K 1,083 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 1 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner | DUOLDuolingo, Inc. Derivative conversion · 10b5-1 plan | C | $1.78M 46.7K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 1 | Iglesias Sanchez OscarDirector |  CDROCodere Online Luxembourg, S.A.Open-market sale · 10b5-1 plan | SELL | $4,647 460 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 0 | Lie SeanChief Technology Officer | CBRSCerebras Systems Inc. Derivative conversion · 10b5-1 plan | C | — 120.0K sh | Sep 28, 2026 traded Sep 25, 2026 |
| 0 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $25K 167 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 0 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $35K 229 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 0 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $21K 136 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 0 | Golechha DipakEVP, Chief Financial Officer | PANWPalo Alto Networks Inc Open-market sale · 10b5-1 plan | SELL | $40K 100 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 0 | Lie SeanChief Technology Officer | CBRSCerebras Systems Inc. Option exercise · 10b5-1 plan | M | — 120.0K sh | Sep 28, 2026 traded Sep 25, 2026 |
| 0 | Mancini AnthonySee Remarks |  RVMDRevolution Medicines, Inc.Option exercise · 10b5-1 plan | M | $105K 3,121 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 0 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner | DUOLDuolingo, Inc. Derivative conversion · 10b5-1 plan | C | — 46.7K sh | Sep 28, 2026 traded Sep 24, 2026 |